🔗 Share this article

This year's Nobel Prize in medical science was awarded for transformative discoveries that illuminate how the immune system targets dangerous pathogens while protecting the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this honor.

Their work identified unique "sentinels" within the defense system that remove rogue defense cells capable of harming the body.

These discoveries are now paving the way for innovative therapies for immune disorders and cancer.

These laureates will share a prize fund worth 11 million SEK.

Decisive Findings

"Their work has been essential for comprehending how the immune system functions and the reason we do not all suffer from serious autoimmune diseases," stated the head of the Nobel Committee.

This trio's research address a core mystery: How does the immune system defend us from numerous invaders while keeping our healthy cells intact?

The body's protection system uses immune cells that search for signs of infection, even pathogens and bacteria it has not met before.

Such cells employ detectors—called receptors—that are generated by chance in a vast number of variations.

That gives the defense network the ability to fight a broad range of threats, but the randomness of the process unavoidably creates white blood cells that may attack the host.

Protectors of the Body

Researchers earlier understood that a portion of these harmful defense cells were destroyed in the immune organ—where white blood cells develop.

This year's award recognizes the discovery of regulatory T-cells—known as the body's "peacekeepers"—which patrol the system to disarm other defenders that attack the body's own tissues.

It is known that this process fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee added, "The findings have laid the foundation for a novel area of investigation and accelerated the development of innovative treatments, for instance for tumors and autoimmune diseases."

Regarding cancer, T-regs block the body from attacking the growth, so research are aimed at lowering their numbers.

For self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is no longer under attack. A similar method could also be effective in reducing the risks of organ transplant failure.

Innovative Studies

Professor Shimon Sakaguchi, of Osaka University, performed experiments on mice that had their immune gland extracted, causing autoimmune disease.

He demonstrated that introducing defense cells from other animals could prevent the disease—implying there was a mechanism for preventing immune cells from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in mice and people that resulted in the discovery of a gene critical for the way regulatory T-cells function.

"The groundbreaking research has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent biological science expert.

"The research is a striking illustration of how basic physiological study can have far-reaching consequences for human health."